MN-3M
Achieving high product purity early in the manufacturing process and improving efficiency and economics is important to biopharmaceutical manufacturers. Increasing removal of impurities like DNA and HCP during clarification improves the performance of downstream capture and polishing steps. The 3M™ Emphaze™ AEX Hybrid Purifier meet these challenges through reduction of cell debris, DNA and HCP at clarification to help improve downstream process steps. The new Emphaze capsules are sterilization/sanitization compatible and can be used across various aqueous based biopharmaceutical processes, including vaccine purification. Additionally, the improved Emphaze AEX Hybrid Purifier products now feature two new laboratory capsules and one scale-up capsule that allows evaluations at laboratory and scale-up volumes.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180905005283/en/
“Customer input is critical in evaluating the performance and effectiveness of any product to maximize performance,” said Himanshu Nivsarkar, Global Marketing Manager, 3M Separation and Purification Sciences Division. “With the Emphaze AEX Hybrid Purifier, customers experience benefits in typical monoclonal antibody purification processes, including nominal 30% HCP and greater than 4 log DNA reduction. It has a consistent output turbidity (<5 NTU) leading to potential downsizing of the sterilizing grade membrane and increased product purity post-protein A. This also reduces turbidity post viral inactivation/neutralization step leading to a lower impurities load on the downstream AEX column, thus allowing customers to optimize their processes.”
Emphaze AEX Hybrid Purifier products are synthetic multi-mechanism single-use purifier products used for biopharmaceutical clarification. They deliver consistent, high purity clarified process fluid by removing soluble and insoluble impurities, such as DNA, HCP, and cell debris, through a combination of chromatographic and size exclusion mechanisms. Emphaze AEX Hybrid Purifier products combine three unique 3M technologies — advanced polymer materials, fine fiber nonwovens, and membranes — to deliver a synthetic clarifying product line containing a novel anion exchange nonwoven media and a fine particle, reduction membrane.
For more information, visit 3m.com/bioprocessing
About 3M
At 3M, we apply science in collaborative ways to improve lives daily. With $32 billion in sales, our 91,000 employees connect with customers all around the world. Learn more about 3M’s creative solutions to the world’s problems at www.3M.com or on Twitter @3M or @3MNews.
3M and Emphaze are trademarks of 3M Company.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180905005283/en/
Contact:
For 3M Emily Sudlow, 612-342-9893 Karwoski & Courage Public Relations emily.sudlow@creativepr.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Lantern Appoints Jeff Williams as Chief Product Officer, Marking Expansion into the US2.9.2025 20:03:00 CEST | Press release
Lantern, the data intelligence platform for private markets, today announced the appointment of Jeff Williams as its first Chief Product Officer (CPO). Based in the United States, Jeff’s appointment marks a major milestone as Lantern establishes its presence in North America, to support its rapidly growing global client base. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250902271705/en/ Jeff Williams, Lantern Chief Product Officer Jeff brings more over 15 years’ experience at the intersection of private markets and technology. Most recently, he served as Chief Strategy Officer at Altvia, where he played a central role in shaping product strategy, guiding product launches, and driving growth. Edward Moore, Founder and CEO of Lantern, commented: “Jeff has a rare blend of product expertise and deep knowledge of private markets. He’s led product strategy through periods of intense growth and complexity, and his experience will
Coherent Solutions secures strategic investment from IceLake Capital to fuel global growth2.9.2025 18:48:00 CEST | Press release
Coherent Solutions, a global digital solutions engineering firm, has secured a strategic investment from IceLake, a leading private equity investor specializing in partnering with high-growth business services organizations. The partnership will accelerate Coherent Solutions’ global expansion and solution offerings, advancing its mission to deliver measurable digital value creation for clients worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250902336956/en/ Coherent Solutions has secured a strategic investment from IceLake, advancing its mission to deliver measurable digital value creation for clients worldwide. This year marks Coherent Solutions’ 30th anniversary. Since its founding in 1995, the company has partnered with some of the world’s largest brands and most ambitious growth companies to design, develop, and launch sophisticated digital platforms and solutions. “The partnership with IceLake is a strong vote
Proteintech Launches “Able” AI – A First-of-Its-Kind Tool to Accelerate Scientific Discovery2.9.2025 17:18:00 CEST | Press release
Proteintech, a global leader in antibodies and life science solutions, today announced the launch of Able AI, a first-of-its-kind artificial intelligence tool that is now available on ptglab.com. Finding the most suitable antibodies from the vast pool of potential products is a challenge. Able helps scientists pinpoint the right antibody based on their research needs, while also providing all relevant information and associated scientific knowledge. In addition, it offers detailed guidance on product specific experimental procedures, significantly reducing the time spent on planning and product selection. This release follows Proteintech’s successful introduction of 3D Epitope Mapping earlier this year, which advanced researchers’ ability to visualize antibody binding sites through experimental and AI-powered modelling. This capability reduces guesswork and trial-and-error, enabling scientists to better design experiments and develop products with greater precision. “Able represents th
MSP Sports Capital Confirms Sale of its Holdings in McLaren Racing to McLaren Group Limited2.9.2025 17:02:00 CEST | Press release
As announced earlier today, McLaren Group Limited has completed the purchase of MSP Sports Capital’s equity interest in McLaren Racing, including its Formula 1 Team. The transaction will enable Bahrain Mumtalakat Holding Company and CYVN Holding, an advanced mobility operator and investment vehicle based in Abu Dhabi, to increase their share and assume full ownership of the iconic British motor racing business. Mumtalakat will continue as majority shareholder with CYVN Holdings owning a non-controlling stake. MSP’s investment came at a pivotal moment in the business, providing vital capital that contributed to the company’s efforts in stabilizing business operations during the COVID-19 pandemic, funding infrastructure upgrades, and retaining and recruiting world-class talent. Over the last five years, with the support received from its shareholders, McLaren has returned to the front of the Formula 1 grid, rebuilt its competitiveness across multiple racing series, and enhanced its long
Textron Aviation Expands ProAdvantage Portfolio With Launch of ProParts+ for Cessna Citation 525 Series2.9.2025 17:00:00 CEST | Press release
Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company, today announced the launch of ProParts+, a new addition to the company’s industry-leading ProAdvantage support programs, designed specifically for Cessna Citation 525 series operators. ProParts+ builds on the trusted foundation of the ProParts program, offering expanded coverage to address key customer identified priorities and enhance operational predictability. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250902524070/en/ Textron Aviation announced the launch of ProParts+, a new addition to the company’s industry-leading ProAdvantage support programs, designed specifically for Cessna Citation 525 series operators. (Textron Aviation) “Expanding our ProAdvantage portfolio with ProParts+ reflects our continued investment in the long-term support of the Citation 525 Series,” said Brad White, senior vice president, Global Parts Distribution. “ProParts+ is a direct res
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom